Tuesday, September 18, 2012

Defense and Security Stock Trading Alert: Kratos (NasdaqGS: KTOS) Continues on Yesterday's Gains

New York, New York - September 18, 2012 (Investorideas.com Newswire, www.homelanddefensestocks.com) Investorideas.com, an investor research portal specializing in sector research including defense and Homeland Defense stocks issues a trading alert for Kratos Defense & Security Solutions, Inc. (NasdaqGS: KTOS) The stock continues on yesterday's gains on news yesterday of a Qatar Satellite deal. The stock is up another 4% in morning trading, currently at $6.04, gaining 0.24 or 4.14% as of 11:12AM EDT on just under 500,000 shares.
Today the Company reported that its SAT Corporation subsidiary has been awarded a contract by the United States Strategic Command (USSTRATCOM) to provide worldwide Radio Frequency (RF) interference geolocation services. The award is valued at $13.2 million if all options are exercised.
Investorideas.com Newswire Kratos Defense & Security Solutions, Inc. (KTOS) is a specialized National Security technology business providing mission critical products, services and solutions for United States National Security. Kratos' core capabilities are sophisticated engineering, manufacturing and system integration offerings for National Security platforms and programs. Kratos' areas of expertise include Command, Control, Communications, Computing, Combat Systems, Intelligence, Surveillance and Reconnaissance (C5ISR), satellite communication systems, unmanned systems, cyber warfare, cyber security, information assurance, and critical infrastructure security. Kratos has primarily an engineering and technically oriented work force of approximately 4,400. The vast majority of Kratos' work is performed on a military base, in a secure facility or at a critical infrastructure location. Kratos' primary end customers are National Security related agencies. News and information are available at www.KratosDefense.com.

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including defense and Homeland Security stocks, biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investor Ideas
800-665-0411 - www.Investorideas.com

Monday, September 17, 2012

Q&A Interview with Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS)

New York, New York - September 17, 2012 (Investorideas.com Newswire, www.homelanddefensestocks.com) Investorideas.com, an investor research portal specializing in sector research including defense and Homeland Defense stocks issues a recent interview with Mr. Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS).

Scott Sacknoff manages the SPADE Defense Index (NYSE: ^DXS), a benchmark for investing in the aerospace and defense sector. It has been licensed to Powershares whose Aerospace & Defense ETF (NYSE: PPA) tracks the performance of the Index.
Investorideas.com staff
Q. Thank you for joining us today. Where do you see the defense market at this time?
Scott Sacknoff, SPADE Defense Index
From a news perspective, most of the attention for the past several months has focused on the impact of sequestration and the fiscal cliff that could occur at year's end; and rightly so. Were it to occur, the impact would be severe, costing well more than a million defense-related jobs and new budget cuts in excess of $50 billion annually over the next decade (or, of course, until Congress changes the plan).  What it means is that investors interested in the sector have been playing it very cautiously.  Trading volumes are down significantly.  Small cap defense stocks as a whole continue to underperform as they have for the past several years although there are some signs of life.  From a historical valuation perspective, aerospace and defense stocks remain highly attractive and, thanks to the calendar roll-over, PPA, which tracks the industry benchmark SPADE Defense Index is hovering near 52-week highs.
Investorideas.com
What do you see as the likelihood of a deal that fixes sequestration issue?
Scott Sacknoff, SPADE Defense Index
I'd like to thank that beyond political posturing, most of our elected officials believe in doing what's best for our country.  Is there waste that could be cut at federal agencies, of course.  However, deliberately pushing our country into recession and double digit unemployment, well that's just insanity.  The reality is that I fear that the fix will come not only after the election but after the new Congress takes office in January and they work on a retroactive solution.  Unfortunately, from an investing perspective, by then the damage will have been done and a big drop in the market would have occurred.  If a solution is reached before the election or immediately thereafter, then there are a number of positives for the sector.
Investorideas.com
So shifting from politics, share with us some bright spots in A&D.
Scott Sacknoff , SPADE Defense Index
As anticipated, commercial aerospace is hitting on all cylinders and once the political issues surrounding the U.S. election are lifted, I'd expect revenues and profits to shift sharply higher.  Boeing has announced increased production levels for the 787 and 737 over the next two years and its new 737 Max has been very well received by the global airlines. This should lead to continued growth in aerospace manufacturing levels through the end of the decade. 
Investorideas.com
Barring sequestration, what do you see for the U.S. defense budget?
Scott Sacknoff , SPADE Defense Index
The specifics are still a bit cloudy. The trend for defense spending has been flattening after the sector grew post-9/11 for nearly a decade. Near-term some decline in total U.S. defense spending is a given as DoD seeks to restructure in a post-war environment while trying to prepare for new and anticipated threats; and all the while try to reduce total spending. An earlier budget  deal agreed to with Congress will see a savings of around $500 billion over the next decade, but the defense leadership sees this level as being manageable with most of the cuts coming from restructuring and eliminating waste.  In fact, as orders from international governments continue to rise, to the tune of more than $60 billion in 2011, I expect this growing line of business could offset some of the effects of the budget restructuring.
Investorideas.com
And the firms?
Scott Sacknoff , SPADE Defense Index
Unlike the post-Soviet collapse era, defense firms have had several years to improve their fiscal situation, shed or spin-off lower margin businesses, and acquire firms to better position themselves going forward.  With valuations low and cash-on-hand high, most companies are very healthy and could ride out this downcycle without major issues.  With margin expansion, we could even see their prices rise over time.  
Investorideas.com
Lastly, how will the presidential election impact the sector?
Scott Sacknoff , SPADE Defense Index
The truth is everything said now is just political posturing. Historically, the defense budgets rise and fall based on the current state of the world and not which party controls the White House.  Budgets rose during Vietnam (Kennedy, Johnson) and fell post-Vietnam (Carter), rose with Cold War tensions (Reagan) and fell after the Soviet collapse (Bush, Clinton), started rising when the cuts seemed to deep (Clinton) and rose post 9/11 (Bush). The budget is likely to see some cuts due to debt reduction and would rise in the event of an Iran nuclear situation or another terrorist attack. Ultimately, it won't matter who is President, it’s the world that matters.
Investorideas.com
Thank you for your time.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including defense and Homeland Security stocks, biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact:
Scott Sacknoff
SPADE Defense Index
www.spadeindex.com
scott@spadeindex.com
Or Investor Ideas
800-665-0411 - www.Investorideas.com

Monday, July 23, 2012

Homeland Defense and Security Q&A Interview with PositiveID (OTCBB: PSID): How the M-BAND System Biothreat Detection is in the Running for BioWatch

New York, NY - July 23, 2012 - (Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an exclusive Q&A interview with Mr. William J. Caragol, Chairman and Chief Executive Officer of PositiveID Corporation (OTCBB: PSID) discussing its M-BAND System for biothreat detection.

Q: Investorideas.com
Can you briefly explain to new investors how the M-BAND System works and how it can be deployed in the BioWatch Generation 3 program?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
Our Microfluidics-based Bioagent Networked Detector, called M-BAND, was developed under contract for the Department of Homeland Security (DHS), and is an early warning system designed to detect the intentional release of aerosolized biological agents. It runs autonomously for up to 30 days between service cycles, continuously analyzing air samples, typically in high-traffic areas, for the detection of bacteria, viruses, and toxins with results in as little as three hours. Results from individual M-BAND instruments are reported via a secure wireless network in real time to give an accurate and up to date status for instruments in the field in aggregate. M-BAND was designed with a high level of operational flexibility, and can be remotely set to detect for DNA-based pathogens alone, with or without either RNA-based organisms or toxins, or for all three types of pathogens simultaneously at remotely programmable intervals.
Q: Investorideas.com
We understand the Department of Homeland Security wants to open bidding before October for Generation 3 of the BioWatch program, now estimated at $5.7 Billion. Where is PSID in the process?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
We are currently awaiting the final RFP from the Department of Homeland Security, which is expected to be released later this year. In the meantime, we have made significant progress in our internal testing of M-BAND, which detects five organisms on the Centers for Disease Control Select Agents List, which is a requirement for BioWatch. Our system is fully functional and, we believe, one of the only technologies capable of addressing the requirements of the BioWatch procurement. We are preparing for potential additional testing of our system as well.
Q: Investorideas.com
The other company bidding for the BioWatch program is Northrop Grumman (NYSE:NOC); is this competitive against your technology or more synergistic?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
We believe the M-BAND instrument offers a number of advantages over similar products, including decreased consumable and operating costs, a small footprint, a closed operating environment and significant flexibility of operation. M-BAND has been designed and field tested (both indoors and outdoors) to operate continuously for 30 days unattended between scheduled services, which we believe to be higher than competing technologies. It also operates using industry gold-standard TaqMan® PCR (polymerase chain reaction) chemistry.
Q: Investorideas.com
Your Company was recently featured in a Bloomberg Businessweek.com article discussing BioWatch; did that lend a new level of credibility for your company being a small OTC listed stock?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
We believe articles like the one published in Bloomberg Businessweek shed light on the need for BioWatch Generation 3, and also highlight and validate our technology and our company. Many people may not have been previously aware of PositiveID or M-BAND, so it was very significant for our company and technology to be featured alongside the likes of Northrop Grumman. We have already received additional inquiries and interest from large corporations around the world including for possible partnership opportunities, as well as increased investor interest.
Q: Investorideas.com
Are you targeting any other markets forthe M-BAND System globally?
A: Mr. William J. Caragol, Chairman and Chief Executive Officer
Unfortunately, terrorism is not limited to the United States, so M-BAND could be deployed in any location around the globe. In fact, the system has been field tested in London.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.www.PositiveIDCorp.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed July 2012 -3500 cash and five hundred thousand shares for three months http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact
PSID:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com: 800 665 0411
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed July 2012 -3500 cash and five hundred thousand shares for three months . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Thursday, July 19, 2012

Homeland Defense Stock Alert: IDO Security (OTC: IDOI) Moves over 27%

New York, NY - July 19, 2012 (Investorideas.com Newswire, www.Homelanddefensestocks.com) www.InvestorIdeas.com, a global investor research portal, specializing in sector research for independent investors, issues a trading alert for Homeland Defense stock, IDO Security Inc. (OTC:IDOI), the developer of theMagShoe™ shoe scanning device (SSD). The stock is trading up at $0.47, gaining 0.10(27.03%) on over 1.8 Million shares.
The average trading volume for the stock is 102,000. There was no news issued from the Company today, but the stock was featured in several microcap newsletters.
Investorideas.com Newswire About IDO Security, Inc.
Headquartered in New York with a subsidiary in Israel, IDO Security designs, develops and markets the patented MagShoe™ shoe scanning device (SSD), filling a critical void in today's detectors by extending screening to the lower body and feet. MagShoe™'s "shoes-on" design maximizes security, thoroughness and accuracy while eliminating the need to remove shoes for increased convenience and safety; neither invasive nor harmful to the body as some of the other screening devices currently used in the marketplace. Ideal for security and loss prevention at virtually any facility, MagShoe™ is currently in use worldwide at international airports, cruise lines, government agencies, correctional facilities, mints and more.

http://www.idosecurityinc.com
Research defense and security stocks with the Investorideas.com defense and security stocks Directory:
http://www.investorideas.com/Companies/HomelandDefense/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Investorideas.com and its defense portal www.Homelanddefensestocks.comwasone of the first sites to cover Homeland Defense stocks and was quoted as a source in Businessweek.com and CNN Financial News on the sector.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/116622008917768549777
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more. Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . I nvestorideas.com was not compensated for this report
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com

Monday, March 12, 2012

Security Stocks; United Protection Security Group Inc. (TSX-V: UZZ) - Acquisition and Corporate Update

EDMONTON - March 12, 2012 (InvestorIdeas.com Newswire) - F.V.Ramsoondar, Chief Executive Officer of United Protection Security Group Inc. ("UPSG" or the "Company"), (TSX-V:UZZ) is pleased to announce the following updates:
a) The Company has successfully closed a Camrose, Alberta asset acquisition of a Physical Security Guard company that currently generates approximately $600,000 in annualized revenues. This acquisition is in line with the Company's objective for expansion across Canada . The total consideration for the asset acquisition is $130,000 , payable by way of $50,000 in cash on or before March 31, 2012 , the closing date, $50,000 in cash six (6) months after closing date and $30,000 in cash nine (9) months after closing date.
b) The Company will not proceed with an Equity Line Financing Facility pursuant to a press release dated July 12, 2010 . With the successful close of a Receivable Financing Facility of USD $4.5 million with a New York Asset Based Lender, the Company is now in discussions with the lender for Term Debt Financing and Equity Financing to be used for future acquisitions.
c) The Company has appointed Mr. Darcy Ogrodnick , CA as its Chief Financial Officer. Mr. Ogrodnick has held various management positions with public companies since 2004, and has been providing financial consulting services to junior exploration companies since 2008. Prior to 2004, he worked for both international and Saskatchewan-based accounting firms serving clients in a number of industries. A Chartered Accountant since 2001, Mr. Ogrodnick holds a Bachelor of Commerce Degree and Master of Professional Accounting degrees from the University of Saskatchewan.
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V: UZZ.V - News), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts.
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. As a result, actual results may vary materially from those described in the forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
United Protection Security Group Inc. is a showcase company on Investorideas.com
Visit the UZZ showcase profile
Get news and updates on UZZ and other stocks
http://www.investorideas.com/Resources/Newsletter.asp

Friday, March 9, 2012

 Security Stock Alert; Smith & Wesson (NASDAQt: SWHC) Shoots up on Third Quarter Results

New York, NY- March 9, 2012 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research for independent investors, issues a trading alert for security,  protection and sport company Smith & Wesson Holding Corporation (NASDAQ :SWHC). The stock is trading up at $6.87, up 1.21(21.38%) 11:13AM EST on over 5 Million shares, making it the NASDAQ top percentage gainer in morning trading.
The stock moved up on financial results for its fiscal 2012 third quarter ending January 31, 2012 reported yesterday on the close.
Your browser may not support display of this image.


Third Quarter Fiscal 2012 Financial Highlights

•Net sales from continuing operations for the third quarter of $98.1 million were up 23.8% from the third quarter last year.  The increase was driven by strong sales of M&P™ handguns, M&P™ sporting rifles, and all Smith & Wesson personal protection and concealed carry pistols. 
•Gross profit for the third quarter was $30.0 million, or 30.6% of net sales, compared with gross profit of $19.4 million, or 24.5% of net sales, for the same period last year.  The improvement in gross profit was driven by increased sales volume and increased overhead absorption due to higher production levels; as well as cost-reduction initiatives across the organization, including the completion of the consolidation of the Thompson/Center Arms business to Springfield, Massachusetts, which concluded in November 2011. In addition, the same period last year included costs associated with the company's strategic price repositioning activities. That strategic repositioning also resulted in lower ongoing promotion costs.
•Operating expense for the third quarter totaled $19.7 million, or 20.1% of net sales, compared with operating expense of $21.3 million, or 26.9% of net sales, for the third quarter last year.  The decrease in operating expense reflected cost-reduction initiatives across the organization as well as reduced legal fees related to the company's ongoing DOJ and SEC investigations.
•Net income from continuing operations for the third quarter was $5.4 million, or $0.08 per diluted share, compared with a net loss from continuing operations of $2.7 million, or $0.05 per diluted share, for the third quarter last year. Net income from continuing operations for the third quarter resulted from increased sales volumes and corresponding gross profit as well as reduced operating expenses.
•Non-GAAP adjusted EBITDAS from continuing operations for the third quarter increased to $14.8 million compared with $4.6 million for the same period last year.
•At January 31, 2012, firearm backlog was $198.5 million, an increase of $124.7 million, or 168.9%, compared with the end of the third quarter last year, and an increase of $48.6 million, or 32.0%, from the most recent sequential quarter. 
•Operating cash flow of $8.5 million and net capital spending of $3.5 million resulted in free cash flow of $5.0 million from continuing operations.
•Debt was reduced by $30.0 million through the repayment of outstanding convertible notes.


About Smith & Wesson
Smith & Wesson Holding Corporation (NASDAQt: SWHC) is a U.S.-based leader in firearm manufacturing and design, delivering a broad portfolio of quality firearms, related products, and training to the global military, law enforcement, and consumer markets. The company's brands include Smith & Wesson®, M&P™ and Thompson/Center Arms. Smith & Wesson facilities are located in Massachusetts and Maine.

Research defense and security stocks with the Investorideas.com defense and security stocks Directory:

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/116622008917768549777

Get Free investor news and stock alerts

Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more . Join: http://www.investorideas.com/membership/

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

800-665-0411 - Source www.Investorideas.com

Thursday, March 8, 2012

Defense and Security Stock Alert; Kratos (NASDAQ:KTOS) up over 11% on Earnings Release

New York, NY- March 8, 2012 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research for independent investors, issues a trading alert for defense and security stock Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS).  The stock is trading up at $6.59 0.66(11.13%) 11:34AM EST with a high of $7.17, making it one of the top NASDAQ morning percentage gainers.

The Company reported Fourth Quarter and Fiscal Year 2011 results and affirmed Previously Issued Fiscal 2012 Adjusted Free Cash Flow Guidance and Provides 2012 Revenue Guidance of $950 Million to $1 Billion.

Financial Highlights:
•Fiscal 2011 Revenues of $723.1 Million Increase 77 Percent Over 2010
•Fiscal 2011 Adjusted EBITDA Margins Increase 300 Basis Points to 12.7 Percent
•Second Half Fiscal 2011 Adjusted Cash Flow from Operations of $27.2 Million
•Fourth Quarter Revenues of $218.2 Million Increase 81 Percent Over Fourth Quarter 2010
•Fourth Quarter Adjusted EBITDA of $27.0 Million, or 12.4 Percent
•Fourth Quarter Book-To-Bill Ratio 1.2 to 1.0, Total Backlog of $1.1 Billion, Bid & Proposal Pipeline $3.7 Billion
•Previous 2012 Adjusted Free Cash Flow Guidance of Approximately $50 Million To $65 Million Reaffirmed
•2012 Revenue Guidance of $950 Million to $1 Billion, Adjusted EBITDA of $120 Million to $130 Million

Your browser may not support display of this image.

Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS) is a specialized National Security technology business providing mission critical products, services and solutions for United States National Security priorities. Kratos' core capabilities are sophisticated engineering, manufacturing and system integration offerings for National Security platforms and programs. Kratos' areas of expertise include Command, Control, Communications, Computing, Combat Systems, Intelligence, Surveillance and Reconnaissance (C5ISR), satellite communication systems, unmanned systems, cyber warfare, cyber security, information assurance, critical infrastructure security and weapons systems sustainment. Kratos has primarily an engineering and technical oriented work force of approximately 4,000, many of whom hold an active National Security clearance, including Secret, Top Secret and higher. The vast majority of Kratos' work is performed on a military base, in a secure facility or at a critical infrastructure location. Kratos' primary end customers are United States Federal Government agencies, including the Department of Defense, classified agencies, intelligence agencies and Homeland Security related agencies. News and information are available at www.KratosDefense.com.

Research defense and security stocks with the Investorideas.com defense and security stocks Directory:

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/116622008917768549777

Get Free investor news and stock alerts

Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more . Join: http://www.investorideas.com/membership/

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp

800-665-0411 - Source www.Investorideas.com

Wednesday, February 29, 2012

What is Bioagent Detection and How Is It Changing Our World?


Since the tragic attacks of September 11th, 2001, and the terrifying Amerithrax case, the world has become ever so aware of the threat of biological warfare and how very real this threat is. However, innovative companies like PositiveID Corporation (OTCBB: PSID) and their subsidiary MicroFluidic Systems have developed a bioagent detection device that will change how our government and military fight biowarfare.
So, what is bioagent detection anyway? Bioagent detection devices test the air for the presence of deliberately-released biological pathogens that are dangerous enough to be used as a biological weapon. Bacillus anthracis, perhaps the most commonly-known bioagent, causes Anthrax, a typically fatal disease. Because some of these hazardous agents can be made from readily-found ingredients, the need for solid protection against these types of deadly attacks continues to grow.
During the weeks immediately following the September 11 attacks, letters containing highlydeadly anthrax spores were sent via the postal system to several prominent news anchors and media offices, as well as two U.S. Senators. Five people were killed and 17 others were infected. For weeks, American citizens were terrorized by news reports of potentially-lethal exposure and warned of the deathly affects. Fearing for their safety, American demanded protection.
In response, the government formed BioWatch, a program to detect the release of airborne pathogens intended as an attack on major United States cities. The program was described as “the nation’s first early warning network of sensors to detect biological attack” and has included a system of filters located within the Environmental Protection Agency’s air filters. Collected data is analyzed by the Centers for Disease Control and Prevention and suspected threats are passed on to the Federal Bureau of Investigation.
However, criticism of the BioWatch program has brought some potential issues to the forefront. Many have expressed concerns about relying on the BioWatch system alone and some have pointed out specific points of possible failure in the system, from poor placement of filters in locations that are not optimal or are likely to incur bio attacks, to sizable gaps in coverage. Some noted that the BioWatch filters kill whatever pathogen has activated them, subsequently eliminating the possibility of further scientific testing. Others claim the current filters would be unable to detect indoor or underground bioagent releases, and would therefore, fail to protect our country in an attack.
Since the birth of BioWatch, the U.S. government and Department of Homeland Security have remain focused on keeping us safe from bio warfare attacks and bioterrorism. Millions have been spent on research supporting the development of better detection devices. America’s demand for a better answer is stronger than ever.
Luckily, PositiveID Corporation’s (“PositiveID”) subsidiary MicroFluidic Systems (“MFS”) developed a bio-threat detection device called M-BAND that will drastically change the world’s ability to defend against bioterrorism.
Developed over eight years, under contract for the Department of Homeland Security (DHS), MBAND is an early warning system designed to detect the presence of intentionally-released aerosolized biological agents. For up to 30 days, M-BAND uses a biocell monitor, running autonomously, continuously collecting samples and analyzing the air. Designed to detect bacteria, viruses, and toxins, these machines can provide results within a mere three hours. Typically placed in high-traffic areas and networked together, M-BAND devices effectively monitor for air-borne pathogens by testing the air every 30 minutes and delivering results through a secure wireless network to a central location for extensive analysis.
After eight years of development, M-BAND offers a real solution. By providing real-time data, M-BAND provides awareness and protection against potential biological warfare attack. Furthermore, M-BAND can be remotely configured to test for all three pathogen types, both simultaneously at programmable intervals or any one in particular, including DNA-based pathogens, with or without either RNA-based organisms or toxins.
Among the bioagents that M-BAND can identify are strains of Bacillus anthracis, also known as anthrax, Yersinia pestis, responsible for causing Black Death and bubonic plague, Francisella tularensis, which causes tularemia or rabbit fever, Burkholderia mallei, which causes Glanders, and Burkholderia pseudomallei, the cause of melioidosis. Because these agents can kill so many people so quickly, an effective warning system is necessary and more important than ever to implement effective quarantine procedures as a line of defense.
The Department of Homeland Security has allocated $3 billion in the budget for bioaresol monitors to setup a network of early warning systems across the country. Luckily, among the large companies and organizations involved with bioagent detection, the unlikely underdog could save the day. The small-but-mighty PositiveID Corporation with M-BAND, an amazing biocell device, is changing the world of bioagent detection.
In a recent press release, PositiveID announced their upcoming presentation of their bioagent detection device called M-BAND at the 10th Annual American Society for Microbiology Biodefense and Emerging Diseases Research Meeting, scheduled to take place from February 26-29, 2012, in Washington, DC. Although smaller than some defense companies, PositiveID Corporation is making big waves on the BioWatch scene. By exhibiting with The Boeing Company, PositiveID stands to change the way the world fights bio warfare and bioterrorism.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the penny stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in small cap and micro cap stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visithttp://www.smallcapvoice.com/services.html.
IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.
Contact:
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com

Security Stock Investor Alert: Magal Security Systems (NASDAQ: MAGS) Closes up over 14%

New York, NY - February 29, 2012 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research for independent investors, issues a trading alert for security stock, Magal Security Systems Ltd. (NasdaqGM: MAGS) for market close February 28th. The stock ended trading at $4.79, up 0.59(14.05%) 4:00PM EST on over 187,000 shares.
Last news from the Company was January 23rd that it had won a US$2.1 million contract to supply and install multi-layer Perimeter Intrusion Detection Systems (PIDS) for two new high security prisons in Latin America.
Investorideas.com Newswire

Magal S3 is a leading international provider of security, safety and site management solutions and products. Over the past 40 years, Magal S3 has delivered tailor-made solutions and turnkey projects to hundreds of satisfied customers in over 80 countries.
http://www.magal-s3.com
Research defense and security stocks with the Investorideas.com defense and security stocks Directory:
http://www.investorideas.com/Companies/HomelandDefense/ Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/ #!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/ Investorideas
Follow Investorideas.com on Google Plus https://plus.google.com/ 116622008917768549777
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/ Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more. Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411 - Source - www.Investorideas.com

Tuesday, February 21, 2012

Biodefense Stock News: PositiveID (OTCBB:PSID) to Present M-BAND at ASM Biodefense and Emerging Diseases Research Meeting February 26-29

DELRAY BEACH, Fla., February 21, 2012 - (Investorideas.com Newswire) PositiveID Corporation's (OTCBB: PSID) subsidiary MicroFluidic Systems (“MFS”), a developer of molecular diagnostic systems, announced today it will present its M-BAND (Microfluidics-based Bioagent Autonomous Networked Detector) system at the 10 th Annual American Society for Microbiology (“ASM”) Biodefense and Emerging Diseases Research Meeting, to be held February 26-29, 2012, in Washington, DC at the Omni Shoreham Hotel. PositiveID will jointly exhibit M-BAND with The Boeing Company (NYSE:BA) and Hamilton Sundstrand.
M-BAND, developed under contract for the Department of Homeland Security by MFS, is an early warning system designed to detect the intentional release of aerosolized biological agents . It runs autonomously for up to 30 days, continuously analyzing air samples, typically in high-traffic areas, for the detection of bacteria, viruses, and toxins with results in as little as three hours. Results from individual M-BAND instruments are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instruments in aggregate. Designed with a high level of operational flexibility, M-BAND can be remotely set to detect for DNA-based pathogens alone, with or without either RNA-based organisms or toxins, or for all three types of pathogens simultaneously at remotely programmable intervals.
According to the ASM, approximately 1,000 leaders and decision makers in the field of biodefense will participate in the Biodefense and Emerging Diseases conference to discuss the critical research necessary to defend against the growing threat of bioterrorism and shape the future of the biodefense research agenda.
About PositiveID Corporation
PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including the likelihood that PositiveID will present its M-BAND system at the ASM Biodefense and Emerging Diseases Research Meeting; the likelihood that PositiveID will jointly exhibit M-BAND with The Boeing Company and Hamilton Sundstrand; the likelihood that approximately 1,000 leaders and decision makers in the field of biodefense will participate in the Biodefense and Emerging Diseases conference to discuss the critical research necessary to defend against the growing threat of bioterrorism and shape the future of the biodefense research agenda; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully commercialize M-BAND; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Contact:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Published at the Investorideas.com Newswire and syndicated blogs
Learn more about PSID at Investorideas.com
http://www.investorideas.com/CO/PSID/
Disclaimer /Disclosure : Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and  company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/

Thursday, February 16, 2012

Chairman and CEO of PositiveID (OTCBB: PSID) Discusses Catalysts for 2012 in Diabetes Market and Homeland Security Market

Chairman and CEO of PositiveID (OTCBB: PSID) Discusses Catalysts for 2012 in Diabetes Market and Homeland Security Market


New York, NY- February 16, 2012 – (Investorideas.com Newswire) Medical Technology Stock news alert: Investorideas.com, a leader in research for independent investors presents an exclusive Q&A interview with Medical technology stock, PositiveID Corporation (OTCBB: PSID). Mr. William J. Caragol, Chairman and Chief Executive Officer discusses the catalysts for 2012 for both its diabetes management technologies and its Homeland Security airborne bio-threat detection technology.

Q: Investorideas.com

We noted that late last year the Department of Homeland Security (“DHS”) Office of Health Affairs began the procurement process for the deployment of an autonomous biodetection system called BioWatch Gen-3. Can you give investors insight as to the potential 2012 opportunities for the Company’s airborne bio-threat detection technology (M-BAND) in this process?



A: Mr. William J. Caragol, Chairman and Chief Executive Officer

Our MicroFluidic Systems (“MFS”) subsidiary, is a leader in biothreat detection technologies and molecular diagnostic systems, and developed its M-BAND technology under contract from DHS over the past eight years. We believe our M-BAND, a Microfluidics-based Bioagent Autonomous Networked Detector, is one of only two technologies that is compatible with DHS’ procurement for Gen-3 of Biowatch, which has a total value of more than $3 billion over approximately five years, as described by the DHS in their draft RFP. This opportunity, relative to the provision of biodetectors and the renewables, represents a very significant opportunity for PositiveID.



Q: Investorideas.com

With your three diabetes management technologies, Easy Check™, GlucoChip™ and iglucose™, can you give investors a quick summary of some of the recent key developments announced by the Company and some of the key drivers for 2012?



A: Mr. William J. Caragol, Chairman and Chief Executive Officer

We continue to make significant progress with each of our diabetes management products. Starting with Easy Check, our non-invasive breath glucose detection device, we completed a prototype device in 2011 and achieved positive preliminary results in early testing that are within industry standards. We recently announced the initiation of a clinical study of Easy Check with Schneider Children’s Medical Center in Israel, led by a world leading endocrinologist. We expect to have results from that study later this year.



Moving on to GlucoChip, a continuous glucose-sensing microchip, we have completed Phase II development and proved a stable and reproducible, closed-cycle continuous glucose sensor that functions in human blood. We also recently provided an update on a biotransport study we are conducting with the Diabetes Research Institute at the University of Miami, which has yielded positive preliminary results. We will continue to provide updates on our progress over the next few months. As those results develop, we will look to work with a partner to incorporate the glucose-sensing system with a micro-electromechanical system signal transduction unit and the electronics of a radio frequency identification microchip to complete development of GlucoChip



Last but not least, we received FDA clearance for iglucose, which is a mobile health system for diabetes management, in late 2011, and are now preparing to roll-out this product with health insurers and home-healthcare providers. As we look ahead to the rest of 2012, we expect that the initial roll-out of iglucose in the first half of the year will be followed by larger orders and partnering agreements.



Q: Investorideas.com

Your technology takes management of diabetes to the clouds literally. With the iglucose technology, the data stored in the diabetes management portal can be shared automatically by text messaging or email. How significant a breakthrough is this for family members, caregivers and healthcare professionals and most importantly, the patient?



A: Mr. William J. Caragol, Chairman and Chief Executive Officer

The value proposition of iglucose is to provide an individual with diabetes flexibility and wireless connectivity to better manage their condition and stay in touch with loved ones. With iglucose, an individual no longer has to keep manual logbooks – iglucose automatically pulls the data from a glucometer and sends it to the cloud. Patients can continue to use their preferred blood glucose meter and there is no cell phone or data plan required. iglucose simplifies diabetes management by automating the process of providing blood glucose readings to healthcare professionals for more informed communication and treatment decisions. iglucose also provides peace of mind for family members that their loved ones are testing and what their values are.



Q: Investorideas.com

Easy Check is your non-invasive breath glucose detection device that measures the level of acetone in a patient's exhaled breath and correlates that acetone level to a measure of blood glucose. With a rapid growth of diabetes in children how significant is it to have a technology that could eliminate a patient's need to prick his or her finger multiple times per day to get a blood sugar reading?



A: Mr. William J. Caragol, Chairman and Chief Executive Officer

Being able to provide the diabetes community with a non-invasive method of testing their blood sugar is often called the “Holy Grail” of diabetes management. Certainly for children, offering non-invasive testing is even more important and appealing. Many times, people with diabetes do not test as often as prescribed by their physician due to the pain and inconvenience of drawing blood.



About PositiveID Corporation

PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.



Statements about PositiveID's future expectations, including the likelihood that its M-BAND is one of only two technologies that is compatible with DHS’ procurement for Gen-3 of Biowatch, which has a total value of more than $3 billion over approximately five years, as described by the DHS in their draft RFP; the likelihood that this opportunity, relative to the provision of biodetectors and the renewables, represents a very significant opportunity for PositiveID; the likelihood that PositiveID will continue to make significant progress with each of its diabetes management products; the likelihood that PositiveID will have results from its Easy Check clinical study later this year; the likelihood that PositiveID will continue to provide updates on its progress with GlucoChip over the next few months; the likelihood that as those results develop, PositiveID will look to work with a partner to incorporate the glucose-sensing system with a micro-electromechanical system signal transduction unit and the electronics of a radio frequency identification microchip to complete development of GlucoChip; the likelihood that PositiveID is now preparing to roll-out this product with health insurers and home-healthcare providers; the likelihood that the initial roll-out of iglucose in the first half of the year will be followed by larger orders and partnering agreements; the likelihood that iglucose simplifies diabetes management by automating the process of providing blood glucose readings to healthcare professionals for more informed communication and treatment decisions; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully complete development and commercialize Easy Check, GlucoChip and iglucose; the likelihood that PositiveID will participate in BioWatch Gen-3; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.



Contact:

Allison Tomek

561-805-8000

atomek@positiveidcorp.com



Learn more about PSID at Investorideas.com

http://www.investorideas.com/CO/PSID/



About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas



Get Free investor news and stock alerts

Sign Up: http://www.investorideas.com/Resources/Newsletter.asp



Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30, 2012. Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and company profile .More info:www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894



Contact Investorideas.com 800 665 0411